| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 57.15M | 65.48M | 37.76M | 11.71M | 7.74M | 5.69M |
| Gross Profit | 8.35M | 16.23M | 11.31M | 2.49M | 1.86M | 1.23M |
| EBITDA | -7.17M | -20.15M | -19.68M | -6.71M | -6.29M | -1.42M |
| Net Income | -8.33M | -14.03M | -3.78M | -9.16M | -8.11M | -2.76M |
Balance Sheet | ||||||
| Total Assets | 30.01M | 36.48M | 64.47M | 28.64M | 20.57M | 4.67M |
| Cash, Cash Equivalents and Short-Term Investments | 13.93M | 19.96M | 26.31M | 18.89M | 17.27M | 728.76K |
| Total Debt | 1.71M | 2.26M | 3.01M | 1.07M | 365.22K | 746.33K |
| Total Liabilities | 8.47M | 9.68M | 16.38M | 2.87M | 3.03M | 4.10M |
| Stockholders Equity | 21.43M | 26.68M | 32.18M | 25.78M | 17.53M | 565.19K |
Cash Flow | ||||||
| Free Cash Flow | -6.31M | -5.65M | -4.24M | -4.32M | -4.32M | -871.88K |
| Operating Cash Flow | -6.30M | -5.46M | -3.60M | -3.60M | -4.09M | -836.98K |
| Investing Cash Flow | 228.00K | -953.00K | 5.20M | -7.72M | -229.31K | -34.90K |
| Financing Cash Flow | -336.00K | 72.00K | 5.86M | 13.01M | 20.82M | 1.57M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
47 Neutral | $17.83M | -5.53 | ― | ― | ― | ― | |
43 Neutral | $12.63M | ― | -80.59% | ― | -27.47% | 83.06% | |
43 Neutral | $20.80M | -1.77 | -354.82% | ― | 34.50% | 70.55% | |
41 Neutral | $20.51M | -1.72 | -37.97% | ― | -14.03% | 52.39% |
NextPlat Corp, a Nevada-based company listed on the Nasdaq, operates in the e-Commerce and Healthcare sectors, providing satellite-enabled communication services and healthcare solutions. In its latest earnings report for the quarter ending September 30, 2025, NextPlat Corp reported a decrease in revenue and a net loss compared to the previous year. The company’s total revenue for the quarter was $13.75 million, down from $15.37 million in the same period last year, with a net loss of $2.19 million. The decline in revenue was primarily due to reduced sales in its Healthcare operations, particularly in the Pharmacy 340B contract revenue. Despite the challenges, the company managed to reduce its operating expenses significantly, which helped to narrow the loss. Looking ahead, NextPlat Corp’s management remains focused on strategic initiatives to enhance its service offerings and improve financial performance, although they acknowledge the uncertainties in the market environment.
In the recent earnings call, NextPlat Corp. presented a mixed performance, highlighting both challenges and opportunities. While the company achieved significant cost reductions and improvements in pharmacy revenue and operational efficiency, it faced a decline in overall revenue and gross margins, primarily due to difficulties in the Healthcare segment. However, the turnaround in the 340B business and strong sales in the e-commerce segment offer a cautiously optimistic outlook.
On October 29, 2025, NextPlat Corp announced that it received a 180-day extension from Nasdaq to meet the minimum bid price requirement for its common stock, which had fallen below $1.00 per share for 30 consecutive trading days. The extension allows NextPlat until April 27, 2026, to regain compliance by maintaining a closing bid price of at least $1.00 per share for ten consecutive business days. This extension does not immediately affect the listing of NextPlat’s stock on Nasdaq, and the company is exploring options, including a reverse stock split, to address the deficiency. Failure to meet the requirement could result in delisting, though NextPlat remains committed to compliance and is closely monitoring its share price.
The most recent analyst rating on (NXPL) stock is a Hold with a $0.50 price target. To see the full list of analyst forecasts on NextPlat stock, see the NXPL Stock Forecast page.
On October 13, 2025, NextPlat Corp announced a leadership transition with the resignation of Cecile Munnik as Chief Financial Officer and the appointment of Amanda L. Ferrio as her successor. Ms. Ferrio, who has been with Progressive Care, a subsidiary of NextPlat, since 2022, brings over 15 years of experience in accounting and finance to her new role. This internal promotion is part of NextPlat’s ongoing efforts to refocus its business and enhance its financial operations. The transition is expected to support the company’s plans to improve financial performance and drive sustainable shareholder value.
The most recent analyst rating on (NXPL) stock is a Hold with a $1.00 price target. To see the full list of analyst forecasts on NextPlat stock, see the NXPL Stock Forecast page.
On September 3, 2025, NextPlat appointed Rodney Barreto as Chairman of the Board and David Phipps as Chief Executive Officer, both previously serving in interim roles following the passing of the former Chairman and CEO in May 2025. The company is executing a business refocusing plan, including leadership changes, new business opportunities in healthcare, and cost-cutting measures like consolidating headquarters operations. These efforts aim to improve efficiency, financial outlook, and long-term growth, with significant implications for shareholders and the company’s market positioning.
The most recent analyst rating on (NXPL) stock is a Hold with a $0.50 price target. To see the full list of analyst forecasts on NextPlat stock, see the NXPL Stock Forecast page.